Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of necroptosis in cancer biology and therapy
Yitao Gong, Zhiyao Fan, Guopei Luo, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 837

Showing 26-50 of 837 citing articles:

Insight into Crosstalk between Ferroptosis and Necroptosis: Novel Therapeutics in Ischemic Stroke
Yue Zhou, Jun Liao, Zhigang Mei, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 117
Ferroptosis as a potential target for cancer therapy
Zhen Chen, Weilong Wang, Siti Razila Abdul Razak, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 110
Advances in mechanism and regulation of PANoptosis: Prospects in disease treatment
Peng Zhu, Zhuo-Ran Ke, Jing-Xian Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 103
The double-edged functions of necroptosis
Keng Ye, Zhimin Chen, Yanfang Xu
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 92
From Molecular Mechanisms to Therapeutics: Understanding MicroRNA-21 in Cancer
Jiho Rhim, Woosun Baek, Yoona Seo, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2791-2791
Open Access | Times Cited: 85
Causes of and Molecular Targets for the Treatment of Intervertebral Disc Degeneration: A Review
Takashi Ohnishi, Norimasa Iwasaki, Hideki Sudo
Cells (2022) Vol. 11, Iss. 3, pp. 394-394
Open Access | Times Cited: 84
Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation
Cong Zhou, Ting Yu, Rui Zhu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 5, pp. 1471-1489
Open Access | Times Cited: 83
Impairing Tumor Metabolic Plasticity via a Stable Metal‐Phenolic‐Based Polymeric Nanomedicine to Suppress Colorectal Cancer
Xiaoling Li, Zhenyu Duan, Xiaoting Chen, et al.
Advanced Materials (2023) Vol. 35, Iss. 23
Closed Access | Times Cited: 69
Paraptosis: a unique cell death mode for targeting cancer
Sweata Hanson, Aiswarya Dharan, P. V. Jinsha, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 58
Copper in cancer: from limiting nutrient to therapeutic target
Xiaolong Tang, Zaihua Yan, Yandong Miao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 57
Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy
Jianfeng Guo, Yifang Zou, Leaf Huang
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 55
Regulated cell death pathways and their roles in homeostasis, infection, inflammation, and tumorigenesis
Ein Lee, Chang‐Hyun Song, Sung‐Jin Bae, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 8, pp. 1632-1643
Open Access | Times Cited: 49
Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis
Jie Yu, Bingling Zhong, Lin Zhao, et al.
Drug Resistance Updates (2023) Vol. 70, pp. 100977-100977
Closed Access | Times Cited: 46
PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment
Jie Gao, Anying Xiong, Jiliu Liu, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 7, pp. 970-983
Open Access | Times Cited: 33
Mediators of necroptosis: from cell death to metabolic regulation
Xiaoqin Wu, Laura E. Nagy, Jérémie Gautheron
EMBO Molecular Medicine (2024) Vol. 16, Iss. 2, pp. 219-237
Open Access | Times Cited: 21
RIPK3 signaling and its role in regulated cell death and diseases
Yaqi Zhou, Yaxuan Xiang, S. Liu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 18
Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 17
Complex roles of autophagy in cancer development, immune evasion, and drug resistance
Xuegang Niu, Qi Sheng You, Kejun Hou, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101170-101170
Closed Access | Times Cited: 17
Employing Piezoelectric Mg2+‐Doped Hydroxyapatite to Target Death Receptor‐Mediated Necroptosis: A Strategy for Amplifying Immune Activation
Jiani Yang, Yaqian Du, Yuanfei Yao, et al.
Advanced Science (2024) Vol. 11, Iss. 13
Open Access | Times Cited: 16
Harnessing ferroptosis for precision oncology: challenges and prospects
Roberto Fernández-Acosta, Iuliana Vintea, Ine Koeken, et al.
BMC Biology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 3
CHMP4C promotes pancreatic cancer progression by inhibiting necroptosis via the RIPK1/RIPK3/MLKL pathway
Longchen Yu, Qining Guo, Yaping Li, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 2
7 I, a structurally modified sinomenine, exerts dual anti‐GBM effects by inhibiting glioblastoma proliferation and inducing necroptosis which further mediates lysosomal cell death
Hong Yang, Bin Jiang, Li Wan, et al.
British Journal of Pharmacology (2025)
Closed Access | Times Cited: 2
Ferroptosis in Cancer: Mechanisms, Therapeutic Strategies, and Clinical Implications
Mina Pourhabib Mamaghani, Seyedeh Nasibeh Mousavikia, Hosein Azimian
Pathology - Research and Practice (2025) Vol. 269, pp. 155907-155907
Closed Access | Times Cited: 2
Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance
Nir Shahar, Sarit Larisch
Drug Resistance Updates (2020) Vol. 52, pp. 100712-100712
Closed Access | Times Cited: 124
Caspase-8-Dependent Inflammatory Responses Are Controlled by Its Adaptor, FADD, and Necroptosis
Bart Tummers, Luigi Mari, Clifford S. Guy, et al.
Immunity (2020) Vol. 52, Iss. 6, pp. 994-1006.e8
Open Access | Times Cited: 111

Scroll to top